Cadazolid

DB11847InvestigationalSmall molecule

Cadazolid has been used in trials studying the treatment of Clostridium Difficile Infection.

Chemical structure of Cadazolid
Formula / weight
C29H29F2N3O8 · 585.561 g/mol (avg)
Code names
ACT-179811

Resolves to

Compound
UNII2OEA2UN10YCAS1025097-10-2ChEMBLCHEMBL3707376PubChem44242317
Structure
InChIKeyXWFCFMXQTBGXQW-GOSISDBHSA-NSMILESOC[C@H]1CN(C(=O)O1)C1=CC(F)=C(OCC2(O)CCN(CC2)C2=C(F)C=C3C(=O)C(=CN(C4CC4)C3=C2)C(O)=O)C=C1

What you can answer from here — as of February 21, 2021

4Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Cadazolid, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In